mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.7 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |